HP-01-001 Simvastatin and the Rho-kinase Inhibitor Y-27632 Prevent Myofibroblast Transformation in Peyronie's Disease-derived Fibroblasts via Inhibition of YAP/TAZ Nuclear Translocation. (1st May 2019)